Future of the renal biopsy: Time to change the conventional modality using nanotechnology

被引：16

作者：

Khosroshahi, Hamid Tayebi ^{[1
]}

Abedi, Behzad ^{[2
]}

Daneshvar, Sabalan ^{[2
,3
]}

Sarbaz, Yashar ^{[4
]}

Bavil, Abolhassan Shakeri ^{[5
]}

机构：

[1] Department of Internal Medicine, Tabriz University of Medical Sciences, Tabriz, Iran

[2] Medical Bioengineering Department, School of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran

[3] Faculty of Electrical and Computer Engineering, University of Tabriz, Tabriz, Iran

[4] School of Engineering-Emerging Technologies, University of Tabriz, Tabriz, Iran

[5] Department of Radiology, Tabriz University of Medical Sciences, Tabriz, Iran

来源：

International Journal of Biomedical Imaging | 2017年 / 2017卷

关键词：

Nanotechnology; -; Diseases;

D O I：

10.1155/2017/6141734

中图分类号：

学科分类号：

摘要：

At the present time, imaging guided renal biopsy is used to provide diagnoses in most types of primary and secondary renal diseases. It has been claimed that renal biopsy can provide a link between diagnosis of renal disease and its pathological conditions. However, sometimes there is a considerable mismatch between patient renal outcome and pathological findings in renal biopsy. This is the time to address some new diagnostic methods to resolve the insuficiency of conventional percutaneous guided renal biopsy. Nanotechnology is still in its infancy in renal imaging; however, it seems that it is the next step in renal biopsy, providing solutions to the limitations of conventional modalities. Copyright © 2017 Hamid Tayebi Khosroshahi et al.

引用